T. Rowe Price Investment Management Portfolio holdings
T. Rowe Price Investment Management, Inc. (TRPIM), a division of T. Rowe Price Group established in August 2022 and headquartered in Baltimore, Maryland, is an active investment manager overseeing hundreds of billions in assets, focusing on equity and fixed-income strategies for institutional clients and sub-advisory mandates. Spun off from the parent company founded in 1937 by Thomas Rowe Price, Jr., TRPIM operates as a distinct entity with around 900 employees, emphasizing a research-driven, long-term approach rooted in fundamental analysis and disciplined risk management. Managing portfolios like large-cap growth and international equity funds, it complements T. Rowe Price’s broader offerings while targeting sophisticated investors such as pension funds and endowments with tailored, high-conviction solutions. Under the leadership of president Rob Sharps, TRPIM upholds the firm’s legacy of integrity and client focus, adapting its founder’s value-oriented philosophy to modern institutional needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Roper Technologies
ROP
|
+$840M |
| 2 |
Cigna
CI
|
+$836M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$788M |
| 4 |
Abbott
ABT
|
+$766M |
| 5 |
Becton Dickinson
BDX
|
+$743M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$1.26B |
| 2 |
Martin Marietta Materials
MLM
|
+$1.05B |
| 3 |
Linde
LIN
|
+$913M |
| 4 |
Intercontinental Exchange
ICE
|
+$865M |
| 5 |
AbbVie
ABBV
|
+$857M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.45% |
| 2 | Healthcare | 20.82% |
| 3 | Consumer Discretionary | 13.33% |
| 4 | Industrials | 10.66% |
| 5 | Financials | 10.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Quaker Houghton
KWR
$2.97B
| $53.2M | 0.03% |
378,092
+17,048
| +5% | +$2.69M |
|
402
Neumora Therapeutics
NMRA
$322M
| $53M | 0.03% |
5,002,799
-225,534
| -4% | -$2.7M |
|
403
Caesars Entertainment
CZR
$6.05B
| $52.5M | 0.03% |
1,569,622
+223,861
| +17% | +$8.86M |
|
404
Crinetics Pharmaceuticals
CRNX
$8.96B
| $51.3M | 0.03% |
1,002,882
-65,650
| -6% | -$3.67M |
|
405
StoneX
SNEX
$8.07B
| $51M | 0.03% |
1,758,621
+34,499
| +2% | +$966K |
|
406
Cabot Corp
CBT
$4.46B
| $50.4M | 0.03% |
551,940
-364,956
| -40% | -$39.2M |
|
407
NovoCure
NVCR
$2.04B
| $50.4M | 0.03% |
1,690,441
-1,115,692
| -40% | -$23.6M |
|
408
Gulfport Energy Corp
GPOR
$3B
| $50.1M | 0.03% |
272,204
+6,791
| +3% | +$1.09M |
|
|
BFS
409
Saul Centers
BFS
$859M
| $49.7M | 0.03% |
1,281,058
-75,234
| -6% | -$3.01M |
|
410
Urban Outfitters
URBN
$6.54B
| $48.9M | 0.03% |
891,609
-74,349
| -8% | -$3.17M |
|
|
AVNS
411
DELISTED
Avanos Medical
AVNS
| $47.9M | 0.03% |
3,011,312
+644,267
| +27% | +$12.8M |
|
|
TWFG
412
TWFG Inc
TWFG
$1.46B
| $47.9M | 0.03% |
1,553,674
+415,159
| +36% | +$12.9M |
|
413
Ollie's Bargain Outlet
OLLI
$4.7B
| $47.7M | 0.03% |
434,257
-297,118
| -41% | -$29.6M |
|
414
Arrowhead Research
ARWR
$12.1B
| $47.1M | 0.03% |
2,507,296
-1,067,277
| -30% | -$22M |
|
|
AAT
415
American Assets Trust
AAT
$1.4B
| $47.1M | 0.03% |
1,793,745
+6,039
| +0.3% | +$165K |
|
416
Advanced Drainage Systems
WMS
$11.2B
| $47M | 0.03% |
+406,544
| New | +$56.4M |
|
417
JFrog
FROG
$11.5B
| $46.8M | 0.03% |
1,592,697
-1,178,153
| -43% | -$35.8M |
|
418
Knife River
KNF
$3.78B
| $46.8M | 0.03% |
+459,955
| New | +$44.9M |
|
419
Matsons
MATX
$6.45B
| $46.7M | 0.03% |
345,999
-7,092
| -2% | -$1.03M |
|
420
Packaging Corp of America
PKG
$22.9B
| $46.6M | 0.03% |
207,029
-61,936
| -23% | -$14.3M |
|
421
Valmont Industries
VMI
$9.46B
| $46.5M | 0.03% |
151,513
-5,865
| -4% | -$1.89M |
|
422
Pool Corp
POOL
$7.33B
| $45.6M | 0.03% |
133,727
-10,210
| -7% | -$3.72M |
|
423
Allegro MicroSystems
ALGM
$8.24B
| $45.2M | 0.03% |
2,065,879
+491,173
| +31% | +$10.5M |
|
424
Nurix Therapeutics
NRIX
$2.79B
| $44.8M | 0.03% |
2,380,428
-167,663
| -7% | -$3.84M |
|
|
SNV
425
DELISTED
Synovus
SNV
| $44.8M | 0.03% |
873,576
+1,043
| +0.1% | +$54K |
|
Similar funds
T. Rowe Price Investment Management's Q4 2024 Portfolio in Review
As of Q4 2024, T. Rowe Price Investment Management held 684 positions worth $162B, down 2.2% from $166B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
T. Rowe Price Investment Management's Q4 2024 filing shows 61 new, 276 increased, 294 reduced and 51 closed positions. Its largest new stake was Cigna: 2,623,729 shares worth $725M. The largest sale was Salesforce, an estimated $1.26B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Investment Management's largest Q4 2024 buy was Cigna: 2,623,729 shares worth $725M.
- T. Rowe Price Investment Management added most to Roper Technologies in Q4 2024, an estimated $840M increase.
- T. Rowe Price Investment Management's biggest Q4 2024 reduction was Salesforce, cutting an estimated $1.26B.
- T. Rowe Price Investment Management fully exited Southwestern Energy Company in Q4 2024, selling an estimated $278M.
- T. Rowe Price Investment Management's ten largest holdings make up 19% of its $162B portfolio in Q4 2024.
- T. Rowe Price Investment Management opened 61 new positions and closed 51 in Q4 2024.
- T. Rowe Price Investment Management's portfolio value fell 2.2% quarter-over-quarter to $162B.
Based on T. Rowe Price Investment Management's 13F filing for Q4 2024, filed 14 Feb 2025.